Ceva Santé Animale
Private Equity Round in 2025
Ceva Santé Animale S.A. specializes in the research, development, production, and marketing of veterinary pharmaceuticals and vaccines for both companion and farm animals. The company provides a diverse range of products, including treatments for behavior, cardiology, nephrology, dermatology, locomotion, parasitology, and reproduction management for companion animals. For farm animals, Ceva offers anti-infective products, vaccines, and reproductive management solutions for cattle, sheep, goats, swine, and poultry. Additionally, the company has developed tools such as the Ceva Lung Program, a mobile application that helps manage lung health in livestock. Established in 1988 and headquartered in Libourne, France, Ceva operates pharmaceutical and research facilities in various countries, including Canada, Brazil, Italy, Hungary, the United States, Japan, Mexico, China, and Canada. The company is actively involved in global welfare initiatives, collaborating with local organizations to enhance animal health and welfare.
Septeo
Private Equity Round in 2024
Septeo Group is a provider of legal technology services aimed at notaries, law firms, corporate legal departments, and real estate property managers. The company offers a range of solutions, including infrastructure management, digital communication, enterprise resource planning (ERP) software, managed cloud services, and outsourcing facilities. By delivering these services, Septeo Group helps its clients simplify their operations and concentrate on their core business activities. The organization is structured to leverage the latest digital tools, ensuring that each entity within the group can focus on its business expertise while providing excellent service to its customers.
The Row
Private Equity Round in 2024
The Row is a designer and manufacturer based in New York, specializing in a diverse range of ready-to-wear clothing and accessories for women, men, and children. The company offers a variety of products, including clothing, eyewear, handbags, and footwear, with an emphasis on fine fabrics and impeccable fit.
Sezane
Venture Round in 2022
Sézane is a French company that specializes in the manufacture of clothing and accessories. It offers a comprehensive range of ready-to-wear apparel, including dresses, footwear, and various lifestyle products. The brand is committed to enhancing quality and creativity in its designs, utilizing premium fabrics to deliver stylish options at competitive prices. Sézane aims to provide customers with high-quality clothing that reflects contemporary trends while maintaining a focus on craftsmanship.
Ceva Santé Animale
Venture Round in 2020
Ceva Santé Animale S.A. specializes in the research, development, production, and marketing of veterinary pharmaceuticals and vaccines for both companion and farm animals. The company provides a diverse range of products, including treatments for behavior, cardiology, nephrology, dermatology, locomotion, parasitology, and reproduction management for companion animals. For farm animals, Ceva offers anti-infective products, vaccines, and reproductive management solutions for cattle, sheep, goats, swine, and poultry. Additionally, the company has developed tools such as the Ceva Lung Program, a mobile application that helps manage lung health in livestock. Established in 1988 and headquartered in Libourne, France, Ceva operates pharmaceutical and research facilities in various countries, including Canada, Brazil, Italy, Hungary, the United States, Japan, Mexico, China, and Canada. The company is actively involved in global welfare initiatives, collaborating with local organizations to enhance animal health and welfare.
M2i Life Sciences
Private Equity Round in 2019
M2i Life Sciences is a French company that specializes in custom synthesis and formulation of niche products across several sectors including healthcare, veterinary medicine, biological crop protection, and organic electronics. The company excels in redesigning synthetic routes and industrial processes for complex molecules, offering clients comprehensive services from product specification to regulatory clearance. M2i operates an R&D center and a cGMP manufacturing plant in France. Additionally, the company manufactures biocontrol products for agricultural ecological transition, focusing on the development of pheromones that provide alternatives to chemical insecticides, thereby promoting biological diversity and animal welfare.